Accelerator, incubator, innovation, and early-stage investor partnership program

WuXi Biologics’ Enable the Molecule Program works with accelerators, seed/venture capital firms, incubators, and other similar programs to provide startups with the necessary tools and resources to expedite biologics and vaccine development. Program features include R&D support, technical assistance, training, resources and access to world-class technology and drug development platforms – all designed to help startups launch quickly and on a path toward accelerated drug development.

Eligibility:
Startups must be an active participant or referred by a Program Partner.

Program Partner Benefits:

Achieve faster ROI and lower drug development cost
Connect with WuXi Biologics related venture capital partners
Offer more expertise and drug development resources
Provide low risk, “turn-key” solutions for your startups
Work with an industry-leading, high-quality, and highly-trusted CRDMO

Startup Benefits:

Reach key drug development milestones faster
Conduct projects “Right-First-Time” with expert advice and access to experienced teams
Streamline project activities via a single point of contact project management system
Achieve significant cost savings from streamlined activities, fewer vendor transactions and single company audit, contract and quality agreements
Benefit from the sole accountability that comes from working with one CRDMO

R&D Support: Get started with R&D credits to accelerate drug discovery and development.

Platform Technology Access: Leverage access to and credits for the use of WuXi Biologics’ technology platforms.

Resources, Education & Guidance: Utilize drug development support, education and guidance from WuXi Biologics’ experts.

Investment and Technology Validation: Gain access to investment funds and partnerships for technology validation.